Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

UNITED THERAPEUTICS Corp Director's Dealing 2021

Mar 19, 2021

30320_dirs_2021-03-19_7f68a221-acdb-463d-b4f1-09e6b941c9e5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: UNITED THERAPEUTICS Corp (UTHR)
CIK: 0001082554
Period of Report: 2021-03-17

Reporting Person: Olian Judy D. (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-03-17 Common Stock M 2103 $76.36 Acquired 7893 Direct
2021-03-17 Common Stock S 2103 $170.00 Disposed 5790 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-03-17 Stock Options $76.36 M 2103 Disposed 2029-06-26 Common Stock (2103) Direct

Footnotes

F1: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.